In the ERN1 cKO ACLT mouse model, more severe loss of proteoglycan in safranin O staining, a significantly higher arthritis score, elevated expression of MMP13 and ADAMTS5, and reduced expression of aggrecan and Col2 were observed (Fig. 2). This evidence concerns the gene ERN1 and arthritic joint disease.